DK128674B - Process for the preparation of tablets containing water-soluble salts of α-carboxyester-substituted phenylmethyl-penicillins or α-carboxyester-substituted phenylmethyl-cephalosporins for oral administration. - Google Patents

Process for the preparation of tablets containing water-soluble salts of α-carboxyester-substituted phenylmethyl-penicillins or α-carboxyester-substituted phenylmethyl-cephalosporins for oral administration.

Info

Publication number
DK128674B
DK128674B DK138070AA DK138070A DK128674B DK 128674 B DK128674 B DK 128674B DK 138070A A DK138070A A DK 138070AA DK 138070 A DK138070 A DK 138070A DK 128674 B DK128674 B DK 128674B
Authority
DK
Denmark
Prior art keywords
carboxyester
substituted phenylmethyl
penicillins
cephalosporins
preparation
Prior art date
Application number
DK138070AA
Other languages
Danish (da)
Inventor
J Dwight
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK128674B publication Critical patent/DK128674B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK138070AA 1969-03-20 1970-03-19 Process for the preparation of tablets containing water-soluble salts of α-carboxyester-substituted phenylmethyl-penicillins or α-carboxyester-substituted phenylmethyl-cephalosporins for oral administration. DK128674B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK128674B true DK128674B (en) 1974-06-17

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK138070AA DK128674B (en) 1969-03-20 1970-03-19 Process for the preparation of tablets containing water-soluble salts of α-carboxyester-substituted phenylmethyl-penicillins or α-carboxyester-substituted phenylmethyl-cephalosporins for oral administration.

Country Status (10)

Country Link
BE (1) BE747656A (en)
DE (1) DE2013039A1 (en)
DK (1) DK128674B (en)
ES (1) ES377725A1 (en)
FI (1) FI51653C (en)
FR (1) FR2035118B1 (en)
GB (1) GB1291281A (en)
IL (1) IL34089A (en)
NL (1) NL143419B (en)
SE (1) SE379284B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (en) * 1970-03-27 1975-08-22 Sankyo Co
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
GB1291281A (en) 1972-10-04
FR2035118B1 (en) 1974-08-30
FR2035118A1 (en) 1970-12-18
NL143419B (en) 1974-10-15
FI51653B (en) 1976-11-30
ES377725A1 (en) 1972-10-16
FI51653C (en) 1977-03-10
DE2013039A1 (en) 1970-09-24
BE747656A (en) 1970-09-21
IL34089A0 (en) 1970-05-21
NL7004004A (en) 1970-09-22
SE379284B (en) 1975-10-06
IL34089A (en) 1974-05-16

Similar Documents

Publication Publication Date Title
DK128053B (en) Process for the preparation of pharmaceutical capsules of hydroxyalkylalkylcellulose ethers.
DK139869B (en) Analogous process for the preparation of phenyl-imidazolyl-alkanoic acid derivatives or salts thereof.
DK132172C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF 6,7-BENZOMORPHANES OR SALTS THEREOF
DK124031B (en) Analogous process for the preparation of phenyl-substituted piperazinylalkylaminouracils, uraciletes or uracilthioethers or salts thereof.
DK135278B (en) Analogous process for the preparation of phenoxyisopropanolamine derivatives or acid addition salts thereof.
DK138424B (en) Analogous process for the preparation of 5-oxopyrido (2,3-d) pyrimidine-6-carboxylic acid derivatives.
DK126788B (en) Analogous process for the preparation of γ-morpholino-p-amino-butyrophenones or salts thereof.
DK129650B (en) Analogous process for the preparation of 1-phenoxy-2-hydroxy-3-amino-propanes or salts thereof.
DK118301B (en) Process for the preparation of antitussive compositions containing dextromethorphan or a salt thereof.
DK128052B (en) Process for the preparation of unit doses in the solid state of medicinal products using sugar as carrier.
DK128674B (en) Process for the preparation of tablets containing water-soluble salts of α-carboxyester-substituted phenylmethyl-penicillins or α-carboxyester-substituted phenylmethyl-cephalosporins for oral administration.
DK123708B (en) Process for the preparation of polyenecarboxylic acids or salts thereof.
DK125245B (en) Process for the preparation of γpiperidinobutyrophenone derivatives or acid addition salts thereof.
DK128496B (en) Process for the preparation of 5-fluorouracil derivatives.
DK125472B (en) Analogous process for the preparation of pyrimidopyridazine derivatives or acid addition salts thereof.
DK126203B (en) Analogous process for the preparation of thiophenoic acid derivatives.
DK135835B (en) Analogous process for the preparation of substituted alkenoic acid derivatives or salts thereof.
DK138490B (en) Process for the preparation of prostadienic acid derivatives.
DK131374B (en) Process for the preparation of 1,4-benzodiazepine derivatives or salts thereof.
DK123527B (en) Process for the preparation of lumilysergic acid derivatives.
DK124885B (en) Analogous process for the preparation of 4-alkenyl-substituted 1,2-diphenyl-3,5-dioxopyrazolidines or salts thereof.
DK126201B (en) Analogous process for the preparation of 1,4-benzodiazepine derivatives or salts thereof.
DK134235B (en) Process for the preparation of salts of alpha-D-glucose-1-phosphoric acid.
DK127878B (en) Analogous process for the preparation of 1-amino-3-phenoxy-2-propanol derivatives or salts thereof.
DK136364B (en) Analogous process for the preparation of 4 (5) -trifluoromethylimidazole derivatives or salts thereof.

Legal Events

Date Code Title Description
PBP Patent lapsed